AstraZeneca (ADR)
Develops oncology-led medicines spanning rare diseases, cardiovascular care, metabolism, respiratory disease, and immunology.
$161.79
After-hours close−0.89 (−0.55%)
At close$162.68(−1.12%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | $2.64 | — | — |
| Jul 2026 | $2.50 | $2.63 | +5.2% |
| Apr 2026 | $2.57 | $2.58 | +0.4% |
| Feb 2026 | $2.09 | $2.12 | +1.4% |
| Nov 2025 | $2.28 | $2.38 | +4.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Jul 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | $2.64 | — | — | $16.05B | — | — |
| Jul 27, 2026 | $2.50 | $2.63 | +5.2% | $15.44B | $15.38B | −0.3% |
| Apr 29, 2026 | $2.57 | $2.58 | +0.4% | $14.93B | $15.29B | +2.4% |
| Feb 10, 2026 | $2.09 | $2.12 | +1.4% | $15.44B | $15.50B | +0.4% |
| Nov 6, 2025 | $2.28 | $2.38 | +4.4% | $14.78B | $15.19B | +2.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 29, 2025 | ||||||
| Apr 29, 2025 | ||||||
| Feb 6, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Jul 25, 2024 | ||||||
| Apr 25, 2024 | ||||||
| Feb 8, 2024 | ||||||
| Nov 9, 2023 | ||||||
| Jul 28, 2023 | ||||||
| Apr 27, 2023 | ||||||
| Feb 9, 2023 | ||||||
| Nov 10, 2022 | ||||||
| Jul 29, 2022 | ||||||
| Apr 29, 2022 | ||||||
| Feb 10, 2022 | ||||||
| Nov 12, 2021 | ||||||
| Jul 29, 2021 | ||||||
| Apr 30, 2021 | ||||||
| Feb 11, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Jul 30, 2020 | ||||||
| Apr 29, 2020 | ||||||
| Feb 14, 2020 | ||||||
| Oct 24, 2019 | ||||||
| Jul 25, 2019 | ||||||
| Apr 26, 2019 | ||||||
| Feb 14, 2019 | ||||||
| Nov 8, 2018 | ||||||
| Jul 26, 2018 | ||||||
| May 18, 2018 | ||||||
| Feb 2, 2018 | ||||||
| Nov 9, 2017 | ||||||
| Jul 27, 2017 | ||||||
| Apr 27, 2017 | ||||||
| Feb 2, 2017 | ||||||
| Nov 10, 2016 | ||||||
| Jul 28, 2016 | ||||||
| Apr 29, 2016 | ||||||
| Feb 4, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Jul 30, 2015 | ||||||